Notiva Labs

Founded in 2020 and based in San Francisco, Notiva Labs operates at the intersection of life sciences and AI/ML, offering a documentation-as-a-service model. The company addresses a critical bottleneck for biotech companies by providing fast, predictable, and high-quality SOP and process documentation, enabling scientific teams to focus on core R&D. Its value proposition centers on an outcome-driven process that ensures documentation is structured, traceable, and ready for internal review and implementation. Notiva Labs serves as a strategic partner for companies navigating regulated environments, aiming to accelerate development timelines by removing documentation hurdles.

Hybrid AI-powered drafting platform combined with human scientific review for generating standardized, review-ready scientific documentation and SOPs.

Notiva Labs competes with internal technical writing teams at large biopharmas, freelance scientific writers, and possibly niche consulting firms. Its differentiation lies in its specialized focus on biotech SOPs, its hybrid AI-human process for speed and accuracy, and its positioning as a partner for scaling, quality-focused teams.